|
John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics, presides over the closing bell. |
| |
John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics, presides over the closing bell |
John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics, presides over the closing bell.
Thursday May 31, 2007
from Nasdaq Marketsite
In New York's Times Square
Amicus Therapeutics
[FOLD] |
| |
Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote
John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics (FOLD), presides over the closing bell to celebrate the Company's initial public offering on NASDAQ.
Amicus Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of a new class of small molecule, orally-administered drugs to treat a range of human genetic diseases.
Reprints
Click for larger pictures of the NASDAQ MarketSite.
Additional Photographs for 05/31/2007
© Copyright 2007, The NASDAQ Stock Market, Inc.
Reprinted with the permission of The Nasdaq Stock Market, Inc. |
|
